Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study

Clinical Trial ID NCT02081404

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02081404

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 8.51
2 Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005 7.35
3 Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999 7.14
4 Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt 2004 5.16
5 An evidence-based appraisal of reflux disease management--the Genval Workshop Report. Gut 1999 3.45
6 A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994 3.14
7 Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999 2.75
8 The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc 2006 2.71
9 Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004 2.67
10 Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998 2.44
11 Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003 2.44
12 Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2006 2.26
13 Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001 2.23
14 Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996 2.14
15 Magnifying endoscopy, stereoscopic microscopy, and the microvascular architecture of superficial esophageal carcinoma. Endoscopy 2002 2.01
16 ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007 1.98
17 Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003 1.91
18 Dilated intercellular spaces: a morphological feature of acid reflux--damaged human esophageal epithelium. Gastroenterology 1996 1.81
19 Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol 2007 1.79
20 Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004 1.60
21 Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001 1.57
22 Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol 2004 1.47
23 A feasibility trial of narrow band imaging endoscopy in patients with gastroesophageal reflux disease. Gastroenterology 2007 1.44
24 Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD. Gastrointest Endosc 2005 1.44
25 Gastroesophageal reflux disease--should we adopt a new conceptual framework? Am J Gastroenterol 2002 1.42
26 Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group. Am J Gastroenterol 2005 1.33
27 Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996 1.28
28 Associations between different forms of gastro-oesophageal reflux disease. Gut 1997 1.21
29 The utility of narrow band imaging in improving the endoscopic diagnosis of gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2008 1.17
30 Symptoms and treatment burden of gastroesophageal reflux disease: validating the GERD assessment scales. Arch Intern Med 2004 1.10
31 Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol 2006 1.02
32 Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig Dis 2004 0.96
33 Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease. Aliment Pharmacol Ther 2003 0.91
34 24-h pH monitoring for gastroesophageal reflux disease: already standard but not yet gold? Am J Gastroenterol 1992 0.90
35 Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice. Scand J Gastroenterol 1997 0.82
36 Interobserver agreement on classifying endoscopic diagnoses of nonerosive esophagitis. Endoscopy 2006 0.82
37 Abstracts of Digestive Disease Week, May 17-22, 2008 and the ASGE (American Society for Gastrointestinal Endoscopy) Postgraduate Course, May 21-22, 2008. San Diego, California, USA. Gastrointest Endosc 2008 0.80
38 Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system. Dis Esophagus 2006 0.80
39 Comparison of hemostatic effects by route of H2 receptor antagonist administration following endoscopic mucosal resection in patients with neoplastic gastric lesions. Aliment Pharmacol Ther 2005 0.75
Next 100